Ultrahuman Expands Blood Vision Nationwide with Revolutionary Wearable Data Integration
Ultrahuman, the health optimization company known for its Ultrahuman Ring and M1 Continuous Glucose Monitoring platform, announced the nationwide expansion of Blood Vision, now available across 48 U.S. states. The platform represents a significant advancement in consumer health technology by merging traditional blood testing with continuous wearable data to create what the company describes as the most advanced consumer-facing system for longitudinal health tracking.
Blood Vision offers comprehensive analysis of over 100 clinically validated biomarkers spanning cardiovascular, metabolic, hormonal, inflammatory, and longevity-related pathways. Key biomarkers include ApoB and Lp(a) for cardiovascular health, fasting insulin and HOMA-IR for metabolic function, free testosterone and TSH for hormonal balance, hs-CRP and IL-6 for inflammation, and biological age metrics for longevity assessment. Each biomarker has been selected for its clinical relevance and predictive power in identifying health risks and optimization opportunities.
The platform's distinguishing feature is UltraTraceâ„¢ technology, which integrates blood marker results with lifestyle data collected from wearable devices. Users can connect their blood chemistry data with sleep, movement, and recovery metrics from the Ultrahuman Ring, as well as glucose patterns from the M1 CGM platform. This integration creates a personalized health model where the relationships between daily behaviors and blood markers become visible and actionable in real time.
"Traditional diagnostics offer a moment-in-time snapshot. Blood Vision transforms this into a longitudinal, predictive model of your health – where insights evolve as you do, and interventions are guided by both real-time lifestyle data and blood marker analysis. The real magic is in between two blood vision tests. Tracking lifestyle biomarkers between two tests allows us establish the relationship between the biomarkers and lifestyle changes. Most people lose track of what to change between two tests, blood vision bridges this gap," said Mohit Kumar, Founder and CEO of Ultrahuman.
The platform delivers all results, trends, risks, and insights through a unified dashboard within the Ultrahuman app. Users receive AI clinician summaries, comprehensive supplementary reports, and performance coaching to translate complex data into actionable health strategies. The inclusion of follow-up testing enables longitudinal tracking of changes, creating a vital feedback loop for measuring and optimizing health improvements over time.
Research indicates that frequent, longitudinal tracking of multimodal data combined with lifestyle metrics can significantly improve early detection of chronic disease. By bridging the gap between static blood tests and continuous lifestyle monitoring, Blood Vision addresses a critical limitation in traditional health assessment approaches.
Click here for the original news story.